Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1 2

Status

Recruiting 4Terminated 1Not yet recruiting 1

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 2

Conditions

Colorectal Neoplasms 56Ovarian Neoplasms 35Carcinoma, Hepatocellular 35Neoplasms 25Fallopian Tube Neoplasms 20Carcinoma, Non-Small-Cell Lung 19Endometrial Neoplasms 13Glioblastoma 11Breast Neoplasms 11Brain Neoplasms 11Neoplasm Metastasis 9Colonic Neoplasms 9Lung Neoplasms 8Uterine Cervical Neoplasms 7Liver Neoplasms 7Rectal Neoplasms 6Glioma 6Biliary Tract Neoplasms 6Stomach Neoplasms 5Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Gastrointestinal Neoplasms 4Digestive System Neoplasms 4Carcinoma, Ovarian Epithelial 4Small Cell Lung Carcinoma 3Sarcoma 3Recurrence 3Peritoneal Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Pancreatic Neoplasms 3

Interventions

Capecitabine 22Oxaliplatin 19Fluorouracil 16Radiotherapy 11Leucovorin 10Cetuximab 9Nivolumab 7Bevacizumab 6sintilimab 5Specimen Handling 5Radiotherapy, Intensity-Modulated 5Magnetic Resonance Spectroscopy 5Irinotecan 5Folfox protocol 5trifluridine tipiracil drug combination 4pembrolizumab 4Surgical Procedures, Operative 4encorafenib 3X-Rays 3Trastuzumab 3Surveys and Questionnaires 3Sigmoidoscopy 3Radiation 3Pemetrexed 3Gemcitabine 3Endoscopy 3Control Groups 3Consolidation Chemotherapy 3Cisplatin 3Carboplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Rectal Neoplasms × Bevacizumab × 90 days × Clear all
NCT06607458 2026-06-01

DEL-LIVER

Delcath Systems Inc.

Phase 2 Recruiting
90 enrolled
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT06997497 2026-05-29

KANDLELIT-012

Merck Sharp & Dohme LLC

Phase 3 Recruiting
477 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT06704724 2026-05-22

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Pfizer

Phase 1 Terminated
30 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

NCT07549399 2026-04-24

CRITâ…¡

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 3 Not yet recruiting
204 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06447662 2026-04-20

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Pfizer

Phase 1 Recruiting
330 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

NCT05806931 2026-03-18

SCOTI

Rutgers, The State University of New Jersey

Phase 2 Recruiting
50 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡